MAPK3 and neoplasm: Furthermore, immunohistochemical staining analysis showed that KO-DUSP4 group increased p-ERK1/2 and decreased cleaved Caspase-3 levels in tumor tissues even with Lenvatinib treatment (Figure 4F and G).